Menu

Immunome, Inc. IMNM

Full chart Compare
Set alert

Price alert · IMNM

All alert types
18.71 USD +0.80 (+4.50%)

At closeNov 6, 2026, 5:50 PM EST

19.55 +0.84 +4.49%

After hours · Nov 6, 5:50 PM ET

17.32 Day range 18.95
15.24 52-week range 29.83
YTD
-12.90%
1 year
+20.71%

Revenue & Expenses

Other Income → Expenses: $1.72MExpenses → Selling, General & Admin: $43.77MExpenses → Research & Development: $174.33MGross Profit → Expenses: $3.99MRevenue → Gross Profit: $3.99MRevenue → Cost of Revenue: $2.96MNet Loss → Expenses: $212.39MOther Income$1.72MGross Profit$3.99MNet Loss$212.39MCost of Revenue$2.96MExpenses$218.10MSelling, General & Admin$43.77MResearch & Development$174.33MRevenue$6.94M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IMNM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.94M9.04M14.02M00
6.94M9.04M14.02M00
-224.11M-305.80M-109.53M-36.90M-25.20M
-212.39M-292.96M-106.81M-36.90M-24.71M
-2.43-5.00-5.38-3.09-2.14
IMNM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
653.69M143.45M98.78M20.42M49.33M
683.19M240.24M148.54M24.05M57.92M
48.84M59.08M28.66M7.39M9.74M
3.85M4.77M1.34M00
634.34M181.16M119.88M16.65M48.19M
IMNM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-190.92M-110.79M-7.57M-28.69M-18.23M
60.80M-85.06M-30.48M-248.00K-79.00K
640.36M240.53M116.41M32.00K27.77M
-9.69M-7.17M-831.00K-248.00K-79.00K
510.24M44.67M78.36M-28.91M9.46M